Background-Presence of prominent left ventricular trabeculation satisfying criteria for left ventricular noncompaction (LVNC) on routine cardiac magnetic resonance examination is frequently encountered; however, the clinical and prognostic significance of these findings remain elusive. This registry aimed to assess LVNC prevalence by 4 current criteria and to prospectively evaluate an association between diagnosis of LVNC by these criteria and adverse events. Methods and Results-There were 700 patients referred for cardiac magnetic resonance: 42% were women, median age was 70 years (range, 45-71 years), mean left ventricular ejection fraction was 51% (±17%), and 32% had late gadolinium enhancement on cardiac magnetic resonance. The cohort underwent diagnostic assessment for LVNC by 4 separate imaging criteria-referenced by their authors as Petersen, Stacey, Jacquier, and Captur, with LVNC prevalence of 39%, 23%, 25% and 3%, respectively. Primary clinical outcome was combined end point of time to death, ischemic stroke, ventricular tachycardia/ventricular fibrillation, and heart failure hospitalization. Secondary clinical outcomes were (1) all-cause mortality and (2) time to the first occurrence of any of the following events: cardiac death, ischemic stroke, ventricular tachycardia/ventricular fibrillation, or heart failure hospitalization. During a median follow-up of 7 years, there were no statistically significant differences in assessed outcomes noted between patients with and without LVNC irrespective of the applied criteria. Conclusions-Current criteria for the diagnosis of LVNC leads to highly variable disease prevalence in patients referred for cardiac magnetic resonance. The diagnosis of LVNC, by any current criteria, was not associated with adverse clinical events on nearly 7 years of follow-up. Limited conclusions can be made for Captur criteria due to low observed prevalence. (Circ Cardiovasc Imaging. 2017;10:e006174.
L eft ventricular noncompaction (LVNC) is a primary genetic cardiomyopathy postulated to result from an altered trajectory of normal endomyocardial embryogenesis. 1, 2 Three phenotypic markers are associated with LVNC: thin compacted layer, prominent left ventricular trabeculation (noncompacted myocardium), and deep myocardial recesses. Currently, the prevalence of this disease remains controversial. [3] [4] [5] Recently, the MESA registry (Multi-Ethnic Study of Atherosclerosis) found a prevalence of LVNC, based on 2 different criteria, of 25% and 43%. 6, 7 
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Cardiac magnetic resonance (CMR) has emerged as an imaging tool for LVNC diagnosis by offering a high contrast of myocardial tissue and accurate visualization of the left ventricular (LV) apex specifically using cine short-axis steady-state free precession (SSFP) sequence compared with earlier studies using echocardiography. 5 On the basis of currently suggested CMR criteria, LVNC can be diagnosed based on linear measurements (ratio between noncompacted and compacted myocardium) at end diastole (Petersen method) 8 or end systole 9 (Stacey method) or mass ratio between total and trabeculae mass 10 (Jacquier method) or fractal dimension-a quantitative measure of the myocardial trabeculae complexity 11 (Captur method) . Several small studies, predominantly case series, have reported increased risk for adverse clinical events, including heart failure (HF), thromboembolism, and ventricular dysrhythmia, associated with this condition. [12] [13] [14] [15] [16] A recent publication, however, showed no association between adverse outcomes and LVNC in Patients Referred for CMR LVNC diagnosis by Petersen and Jacquier criteria in patients with dilated cardiomyopathies. 17 Because of multiple clinical criteria for the diagnosis of LVNC, and the high prevalence of patients meeting criteria for LVNC with questionable clinically significant outcomes, it is a challenge for the clinician interpreting CMR studies as to when to report LVNC as a diagnosis by CMR. Therefore, this study aimed to examine a large singlecenter registry of CMR patients to determine LVNC prevalence separately by all the previously proposed methods and to assess an association with LVNC and the following clinical outcomes: mortality, ischemic stroke, sustained ventricular tachyarrhythmia/ventricular fibrillation (VT/VF), and HF hospitalizations.
Methods
The study was approved by the institutional research ethics board, and each study participant provided informed consent for CMR and enrollment of biographical data into the registry. There was no external funding used to support this work. The authors are responsible for the design and conduct of this study, all data analysis, drafting, editing of the article and its final content.
Study Population
We prospectively enrolled 700 consecutive patients referred to a Brooklyn, New York, CMR center between May 2006 and January 2010, who are >18 years of age. Of those, 22% of the patients were referred for the evaluation of cardiomyopathy, 19% for suspected coronary artery disease, and 17% for known coronary artery disease, 15% for valvular disease, 8% for intracardiac mass, 5% for syncope/arrhythmia, 5% for pericardial disease, 5% for congenital heart disease, and 4% for stress CMR. We excluded patients with complex congenital heart disease, prior valve surgery, severe valvular disease requiring surgical intervention, or inadequate/incomplete imaging ( Figure I in the Data Supplement). One hundred twenty-two patients were excluded from the analysis because of inadequate imaging-out of those, 59 had significant supraventricular arrhythmia at the index scan, 51 were unable to follow breathing instructions, and 12 patients had incomplete exams. Formal survival analysis was not performed in this cohort because of limited power. . NC/C myocardium at the end diastole using long axis >2.3 to diagnose disease. NC/C: 18.5/7.2=2.6; B, Stacey method to assess for left ventricular NC (end-systolic NC/C ratio). NC/C myocardium at the end systole using short axis >2 to diagnose disease. NC/C: 15.1/5.2=2.9; C, Jacquier method to assess for left ventricular NC (mass). NC/C myocardial mass*100% >20% to diagnose disease. NC mass=total mass−compacted mass. Compacted left ventricular mass 94.6 g. Total left ventricular mass 177.1 g. NC/C mass ratio=177.1 −94.6/94.6*100%=46.6%. D, Captur method to assess for left ventricular noncompaction (fractal dimensions [FDs] ). FD >1.392 to diagnose disease. Short-axis SSFP image binarized using automatic threshold (A), then processed using automatic edge detection (B). Then, result image is analyzed using fractal analysis box-counting method with decreasing box size (C). The graph plots natural logarithm of box count against natural logarithm of scale (box size relative to image size (D). The slope for best of fit line represents FD. FD=1.43. LVNC in Patients Referred for CMR
Magnetic Resonance Image Protocol
CMR studies were performed with a 1.5-T CMR system Magnetom Avanto (Siemens Healthcare) using standard pulse sequences. Before contrast administration, SSFP retrospectively gated well-balanced breath-held images covering the left ventricle from the mitral valve annulus to the apex were obtained for the evaluation of LV function. Three-chamber, 4-chamber, and 2-chamber (both right and left sided) SSFP images were also acquired according to the American Heart Association imaging recommendation. 18 The CMR parameters of the cine SSFP sequence were as follows: bandwidth 125 kHz, flip angle 45°, repetition time to echo time 3.7/1.6 ms, field of view 32 cm, field of view phase 75%, sampled image matrix 256×192, slice thickness 8 mm, and gap 2.0 mm.
All patients received gadolinium-based contrast for assessment of late gadolinium enhancement (LGE) using integrated parallel acquisition technique for both single shot and segmented images. 19 Post-contrast images were visually analyzed for the presence of LGE and subsequently divided into 2 groups, ischemic versus nonischemic, based on available LGE pattern and clinical data: ischemic cardiomyopathy was defined as the presence of subendocardial LGE in a coronary artery distribution, in patients with left ventricular ejection fraction (LVEF) <50%; all other patients with LVEF <50% were categorized as having nonischemic cardiomyopathy. High-risk LVNC patients were defined as having presence of at least one of following: (1) positive family history of LVNC, (2) symptoms consistent with diagnosis of LVNC, (3) neuromuscular disease that is known to be associated with LVNC, and (4) evidence of prior diagnosis of potentially malignant arrhythmias, thromboembolic events, or HF
Ejection Fraction and Mass Assessment
For volumetric and mass assessment, we used Siemens ARGUS software. We used a technique described by Bourantas et al 20 to perform calculations of LV and right ventricular ejection fractions. Data were stratified by sex and categorized as preserved (LVEF ≥50%), mild to moderately reduced (LVEF=36%-49%), and severely reduced (LVEF ≤35%).
Assessment of Left Ventricular Trabeculations

Petersen Method
A long axis was drawn from the level of the mitral valve mid orifice to the LV apex to orient the chamber. The LV true apex or apical cap was demarcated at the end of the LV cavity, and the myocardium beyond this was omitted from measurements. On the basis of prior published CMR protocols, LVNC was qualitatively assessed by evaluating long-axis SSFP cine images for a distinct 2-layered appearance of medium signal intensity, trabeculated noncompacted endocardium tissue interspersed with bright signal intensity blood, versus medium signal intensity compacted endocardium tissue without an inclusion of blood. Within an assessed segment, noncompacted layer was measured at the point of maximal trabecular thickness perpendicular to the 2-layer border. Compacted wall thickness was measured using the same segment at the point of maximal thickness. Care was taken to exclude the tubular papillary muscles and the true apex from the measurements. A ratio of noncompacted/compacted >2.3 in any segment during end diastole established the presence of LVNC 8 ( Figure 1A ).
Stacey Method
The same operators followed the methodology described above with noncompacted/compacted measurements being done at end systole using short-axis SSFP images. Noncompacted/compacted ratio>2 was used to define the presence of LVNC 9 ( Figure 1B ).
Jacquier Method
Collections of SSFP contiguous short-axis slices of the entire LV chamber from the apex to the mitral atrioventricular ring were plotted using Siemens Argus software (Siemens Healthcare). To measure total LV mass, we used a stack of short-axis cines and traced the epicardial border and endocardial borders including both trabeculation and papillary muscles in the end diastole. To measure compacted LV mass, we adjusted endocardial tracings to exclude trabeculations and include papillary muscles. If the operator was not able to differentiate between papillary muscle and trabeculation based on all available images, then it was treated as a trabeculation. The mass of trabeculation was derived as a difference between total and compacted mass. Mass of LV trabeculation >20% of total LV mass established the presence of LVNC 10 ( Figure 1C ). (25) 522 (75) 23 (3) 677 ( (10) 26 (9) 43 (10) 0.93 20 (13) 49 (9) 0.15
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Captur Method
Fractal analysis proposed by Captur et al 11 was performed and described in detail elsewhere. In short, we used ImageJ software version 1.48 (National Institute of Health, Bethesda, MD) using Isodata version 1.15 autothreshold operator to binarize analyzed image. Endocardial border extraction was done using Sobel operator. We used FracLac plugin version 2.5 for deriving the fractal dimension (FD). 21 For box-counting analysis, we set the minimal spacing to 45% of an endocardial border and minimal box size to 2 pixels. We recorded maximal FD for an apical third of the left ventricle excluding the most apical short-axis slice because of partial voluming. FD max apical of ≥1.392 was considered diagnostic for LVNC 11 ( Figure 1D ).
Outcomes
The diagnostic outcome was a prevalence of LVNC based on each of the 4 applied criteria. The primary outcome was time to combined end point of all-cause mortality, ischemic stroke, VT/VF, or hospitalization for worsened HF. The secondary outcomes were (1) all-cause mortality and (2) time to the first occurrence of any of the following events: ischemic stroke, VT/VF, or hospitalization for worsened HF. Ischemic stroke was confirmed by a clinical presentation with a focal neurological deficit and confirmation on computerized tomography/magnetic resonance brain imaging. Sustained VT/VF was identified as at least 30 seconds of hemodynamically stable VT or hemodynamically unstable VT/VF of any duration, as documented by presenting electrocardiograms or implanted pacemaker or defibrillator data. Hospitalization for worsened HF was defined as new-onset or worsening (gradual or rapid) signs and symptoms of HF that require urgent therapy and result in hospitalization.
Data Collection
Three experienced level 3 physicians performed CMR LVNC measurements. Information concerning clinical events and mortality status were obtained at regular intervals of every 6 months after initial CMR. A site-standard questionnaire was used to interview patients on the day of CMR imaging and during follow-up. Data were collected by investigators blinded to the CMR results through either standardized telephone interview with the patients or, if deceased, with family members; contact with the referring physician; and review of inpatient and outpatient medical records when necessary to confirm the outcome. If data were lacking or conflicting, hospital charts were reviewed by independent cardiologists, blinded to the CMR results, to adjudicate these events.
Statistical Analysis
All calculations were performed using STATA 14.1 (StataCorp, TX) software. To minimize potential impact of the multiple test, a P value of <0.01 was considered statistically significant. [22] [23] [24] [25] We present continuous data as mean and SD for normally distributed variables or median and interquartile range for non-gaussian-distributed variables. We present categorical data as frequencies. Continuous variables were compared using Mann-Whitney test. The χ 2 test was performed for categorical variables. If a patient experienced multiple adverse events, only the first occurrence of any event was counted toward the primary and secondary events in the respective analyses, and they each were counted as one primary or secondary outcome. The primary and secondary clinical outcomes were analysed using multivariable Cox proportional hazard model. We used forward and backward selection to identify controlling variables. Respective analyses were contorolled for age, sex, body mass index, presence of diabetes mellitus, LV and right ventricular ejection fraction, presence of LGE,indication for CMR and interaction term for between method used and CMR indication. Because of small number of Captur-positive patients, we controlled those analyses for age and LVEF percentage only. The proportional hazard assumption was confirmed using Schoenfeld residuals (P for each LVNC criteria >0.3; P for global test >0.2) and by the scaled Schoenfeld residuals plot. Receiveroperating characteristic analysis was used to compare prognostic perfomance of the continuous parameters used to define the presence of LVNC. We analyzed continuous noncompacted/compacted ratio at end diastole and end systole used in Petersen and Stacey cohort, respectively, trabeculation mass ratio for Jacquer method and FD max apical for 
Results
We applied the above-mentioned criteria to diagnose LVNC in the 700 patients who underwent CMR. The majority of patients included in this cohort were men (58%), with a median age of 60 years (interquartile range, 45-71 years) and mean body mass index of 28 kg/m 2 (±6). Sixty percent of the patients had hypertension, and approximately a quarter had a history of diabetes mellitus and 25% were previously diagnosed with congestive heart failure. On the basis of the CMR examination, the mean LVEF was 51% (±17%), and 32% had presence of LGE by CMR ( Table 1) .
The prevalence of LVNC by the Petersen criteria was 39%, Stacey criteria was 23%, Jacquier criteria was 25%, and the Captur criteria was 3%. Correlations between all examined criteria are summarized in Figure 2 . Of note, all patients who met Captur criteria for LVNC also met the diagnosis by the other 3 criteria. In patients who met LVNC criteria by the Stacey method, there was a greater baseline prevalence of prior clinical HF (29% versus 17%; P<0.01), severely reduced LVEF <35% (42% versus 15%; P<0.01), and the presence of scar (29% versus 16%; P<0.01). A lower mean LVEF was noted among patients satisfying Stacey criteria (42% versus 53%; P<0.01; Table 1 ).
Over a median follow-up of 82 months (interquartile range, 53-102 months), there were a total of 253 events recorded in 209 patients: 134 deaths (30 cardiac, 19 noncardiac, and the rest with unknown cause), 91 hospitalizations for congestive heart failure, 16 patients had a stroke, and 12 patients had malignant ventricular arrhythmias, as 39 patients had multiple clinical events (of which only 1 was included in the analysis). Multivariable analysis showed no association between studied outcomes and any of the LVNC diagnostic criteria (Table 2; Figure 3 ; Figures II and III in the Data Supplement). As expected, age, presence of diabetes mellitus, LVEF, right ventricular ejection fraction, and presence of LGE were significant independent predictors of all studied outcomes, all P<0.01. There was no interaction between criteria used for analysis, indication for the CMR, and all measured outcomes (all P>0. 2). We performed a receiver-operating characteristic analysis for continuous variables used for LVNC discrimination in 4 cohorts. Receiver-operating characteristic outcome curves of the Petersen, Stacey, Jacquier, and Captur cohorts were nearly superimposable among themselves and with nondiscriminatory diagonal, confirming limited prognostic value for studied primary and secondary outcomes (Figure 4) .
Additional analyses evaluating associations of the examined criteria with primary and secondary outcomes were done in patients with preserved and reduced ejection fraction (Table I in the Data Supplement). The latter group was then divided for further analysis into ischemic versus nonischemic cardiomyopathy based on the presence and pattern of LGE on CMR. There were 283 patients (40%) with reduced LVEF, of whom 164 patients (58%) had nonischemic cause of the P represents P value for the analyzed criteria in a multivariate regression. P-interaction represents P value for interaction between analyzed criteria and referring indication for the CMR study. CI indicates confidence interval; CMR, cardiovascular magnetic resonance imaging; HF, heart failure; HR, hazard ratio, VF, ventricular fibrillation; and VT, ventricular tachycardia. LVNC in Patients Referred for CMR 
Variability Analyses
There was a good reproducibility for all methods tested with intraobserver and interobserver agreement ranging from 80% to 100% and κ ranging from 0.58 to 1 (Table 3) .
Discussion
The main findings of this study were a high prevalence of LVNC by all criteria, except Captur, in nonselected patients referred for CMR. The second main finding is the absence of a correlation between the diagnosis of LVNC by any of the analyzed criteria and any of the clinical outcomes. Observed high LVNC prevalence (39%) based on Petersen criteria is in line with earlier reports from the MESA registry ranging from 25% to 43%. 6, 7 Another study evaluating 1651 healthy volunteers who underwent CMR scan reported a high prevalence meeting Petersen and Jacquier criteria for LVNC, 26 similar to our findings. Although fewer patients were diagnosed by the LV mass analysis of Jacquier method, this is consistent with its reported lower prevalence of LVNC-positive cases compared with the Petersen method. 10, 17 An end-systolic noncompacted/compacted ratio >2 measured by an echocardiography was initially proposed by Jenni to diagnose LVNC; and Stacey adopted this criteria using CMR and found LVNC to be an independent predictor of adverse events in a cohort of 122 patients. 9, 27 Observed prevalence with Stacey criteria is similar to the echocardiographic findings (24%) among HF patients. 28 Fractal analysis is a method of quantifying the complexity of the geometric patterns using sophisticated mathematical model. Its use to diagnose LVNC was recently described by Captur and later validated using data from the MESA registry. 11, 29 Overall observed mean FD max apical were slightly higher than that observed in MESA (1.219 versus 1.199, respectively). These findings can be explained by inclusion of patients with conditions associated with high FD max apical (such as hypertrophic cardiomyopathy), higher prevalence of hypertension, advanced age, higher body mass index, higher LV mass index, and higher LV end-diastolic volume index in our group compared with the MESA cohort.
Previous studies suggested a significantly higher incidence of HF (≤50%), thromboembolism, and arrhythmias, including sudden cardiac death in patients diagnosed with LVNC. [12] [13] [14] [15] [16] This study did not find any association between the presence of LVNC by any of the examined definitions and studied clinical outcomes. A study from the MESA population evaluated 2742 patients and found a similar numeric incidence of adverse clinical events between quintiles based on end-diastolic noncompacted/compacted ratio. 7 In view of a low event rate, formal statistical analysis was not performed in their study. In our analysis, the overall event rate was 4 times higher than the MESA study (17.6% versus 4.4%), enabling us to perform a formal analysis. The difference in the event rate can be explained by the different population studied, as the MESA study was a screening study compared with our study evaluating patients CMR based on clinical indications. This is reflected in the high prevalence of both myocardial infarction (18%) and left ventricular systolic dysfunction found in our population. Our findings coincide with observations from a multicenter registry, which demonstrated no prognostic impact of hypertrabeculation satisfying Petersen and Jacquier LVNC CMR criteria compared with conventional predictors during a mean follow-up of 48 months in 113 patients with LVNC diagnosis by echocardiography and referred for CMR. 30 In 122 consecutive CMR patients, Stacey's group found a strong correlation of LVNC with the combined end point of all-cause mortality, HF admissions, embolic events, and 9 These findings are limited by small sample size, unknown length of follow-up, and use of binary variables rather than time-to-event analysis. In our analysis, Stacey criteria were not associated with our studied end points. Our report is similar with a previous study, 17 which found no additional risk associated with LVNC by Petersen and Jacquier criteria in patients with nonischemic cardiomyopathy during a 3.4-year follow-up. Interestingly, in nonhypertensive patients, Captur criteria was predictive of the primary outcome and all-cause mortality in a univaritate analysis; yet in the mutlvariable model association became non significant.
Another study suggested that the severity of LVNC assessed by Petersen criteria (with noncompacted/compacted ratio >3.0) is associated with worsened recovery of LV systolic function, progression of HF symptoms, higher incidence of nonelective cardiac hospital admissions, and tachyarrhythmia in patients presented with suspected cardiomyopathy. 16 These conclusions were made based on a small cohort (42 patients). We evaluated our data with a noncompacted/compacted ratio >3 by Petersen criteria and did not observe any associations between higher events and LVNC. Additionally, receiveroperating characteristic curve analyses suggest an absence of the additional prognostic information with using higher cutoff values in all methods since curves were nondiscriminatory for both the primary outcome and mortality. The lack of association between clinical outcomes and LVNC diagnosis and LVNC severity noted after 7 years of median follow-up would suggest limited use of the current criteria for clinical decision making, in this broad population, and urgent need to revisit current diagnostic approaches for this condition. Furthermore, our findings, along with totality of data, call for the necessity of prospective validation studies for proposed methods before introducing them into clinical practice.
There are a few limitations of this study: the study was performed at a single center and may not reflect the general population; however, the large number of patients helps to partially mitigate this issue, and in addition, we found a similar prevalence by all methods to previous studies. Another potential limitation of this work stems from the inclusion of all comers for CMR examination leading to the nonspecific patient population, and, therefore, formal clinical LVNC evaluation is not available in every patient. As this study is addressing all comers for CMR and it is not addressing specific population referred with clinical scenarios suggestive of LVNC, it remains a common clinical conundrum for the practicing Figure 3 . Kaplan-Meier survival estimates for primary outcome and applied criteria. A, Event-free estimates for primary outcome by Petersen criteria. B, Event-free estimates for primary outcome by Stacey criteria. C, Event-free estimates for primary outcome by Jacquier criteria. D, Event-free estimates for primary outcome by Captur criteria. LVNC in Patients Referred for CMR physician in how to interpret and how to report findings of extensive trabeculation meeting currently proposed LVNC criteria. No definite conclusion can be made regarding prognostic power of the Captur criteria because only 23 patients meet this definition were identified, and only 11 patients (30%) had an event during the follow-up. A larger, multicenter registry is needed to correctly address prognostic power of the Captur definition of LVNC.
Conclusions
Current criteria for the diagnosis of LVNC leads to highly variable disease prevalence in patients referred for CMR. The diagnosis of LVNC, by any current criteria, was not associated with adverse clinical events on nearly 7 years of follow-up. Limited conclusion can be made for Captur criteria due to low observed prevalence.
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Figure 4.
Receiver-operating characteristic (ROC) analysis for primary and secondary outcomes. A, ROC analysis* for primary outcome: combined end point of all-cause mortality, ischemic stroke, ventricular tachyarrhythmia/ventricular fibrillation, congestive heart failure (CHF) hospitalization. B, ROC analysis* for all-cause mortality. C, ROC analysis* for combined secondary end point of cardiovascular death, ischemic stroke, VT/VF, and CHF hospitalization. We used measurements of trabeculation by each of the criteria as a continuous outcome: Petersen method: NC/C ratio at end diastole using long-axis view. Stacey method: NC/C ratio at end systole using short-axis view. Jacquier method: noncompacted to total mass. Captur method: maximal apical fractal dimension. *We used measurements of trabeculation by each of the criteria as a continuous outcome: Petersen method: NC/C ratio at end diastole using long-axis view. Stacey method: NC/C ratio at end systole using short-axis view. Jacquier method: noncompacted to total mass. Captur method: maximal apical fractal dimension. 
